Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1100 of 5804
-
Engineered immune cells take aim at Hard-to-Treat blood cancer
Disease control Not yet recruitingThis study is a single-center, open-label, dose-exploration trial designed to evaluate the tolerability and safety of different doses of IASO104 in patients with relapsed/refractory plasma cell neoplasms, determine the recommended dose of IASO104, and assess its pharmacokinetic a…
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Aspirin after brain bleed: could a common pill prevent another disaster?
Disease control Not yet recruitingBEAT ICH will be a pragmatic, randomised, placebo-controlled, blinded, superiority clinical trial aiming to recruit 5676 patients aged ≥18 years who survive ICH and assign them 1:1 to starting antiplatelet monotherapy (Aspirin 75 mg od) versus placebo for the entire duration of t…
Phase: PHASE3 • Sponsor: Christian Medical College and Hospital, Ludhiana, India • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control Not yet recruitingThe study enrolled patients with advanced or metastatic NSCLC harboring HER2 mutations, amplification, or overexpression who had progressed after ≥1 prior lines of anticancer therapy. After enrollment, participants received treatment with rezetamab plus pertuzumab until disease p…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Blood test may spot cancer recurrence months before scans
Knowledge-focused Not yet recruitingThis study aims to evaluate the clinical performance of blood-based Minimal Residual Disease (MRD) testing using circulating tumor DNA (ctDNA) in patients with endometrial and cervical cancer. The researchers will investigate whether MRD detection can identify cancer recurrence e…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New gel treatment could soothe diabetic eyes
Disease control Not yet recruitingThe purpose of this study is to determine whether poly(β-amino ester)(PAE)hydrogel loaded with tRNA-derived fragments-antisense oligonucleotides-exosomes(tRF-ASO-Exo) could alleviate symptoms in patients with diabetic ocular surface diseases(DOSD).
Phase: PHASE2 • Sponsor: Affiliated Hospital of Nantong University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug cocktail aims to wipe out esophageal tumors before surgery
Disease control Not yet recruitingThis is a prospective, phase II, exploratory clinical trial. The study aims to evaluate the efficacy and safety of in combination adebrelimab with nimotuzumab and chemotherapy as neoadjuvant therapy in patients with resectable esophageal squamous cell carcinoma. The primary end…
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Hair loss drug showdown: tofacitinib vs methotrexate in new trial
Disease control Not yet recruitingThis study will compare two oral medicines-tofacitinib and methotrexate-for treating severe alopecia areata, including alopecia totalis (loss of all scalp hair) and alopecia universalis (loss of scalp and body hair). Alopecia areata is an autoimmune condition that can cause signi…
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Umbilical cord cell infusion aims to prevent painful mouth sores in transplant patients
Prevention Recruiting nowThis study aims to see if a single intravenous infusion of a cell therapy called Amimestrocel injection can help prevent severe mouth sores (oral mucositis) in patients receiving a stem cell transplant. Patients getting a stem cell transplant often receive strong chemotherapy (w…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Can an Anti-Gravity treadmill or supplements beat knee arthritis pain?
Symptom relief Not yet recruitingHere is a \*\*concise, clear summary (\~250 words / well under 5000 characters)\*\* while preserving the key scientific points: \--- Knee osteoarthritis (KOA) is highly prevalent among overweight women, affecting more than 30% of those with BMI ≥25 kg/m². Excess body weight inc…
Phase: PHASE3 • Sponsor: Badr University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New heart tests aim to catch damage early in kids treated for cancer
Diagnosis Not yet recruitingThe goal of this prospective interventional study is to improve the detection of subclinical chronic Cancer Therapy-Related Cardiovascular Toxicity (CTRCT) and evaluate the added value of advanced cardioechography, ergospirometry, and specific biomarkers in pediatric cancer survi…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New hope for PNH patients: experimental drug HS-10542 enters human trials
Disease control Recruiting nowThis was a phase 1b/2,open label, multi-center study to assess efficacy and safety of HS-10542 in adulte patients with paroxysmal nocturnal hemoglobinuria (PNH) with signs of active hemolysis.
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Ear-Zapping therapy aims to get Parkinson's patients walking better
Disease control Recruiting nowThe goal of this clinical trial is to learn if transcutaneous auricular vagus nerve stimulation (taVNS) can improve gait and brain function in people with diagnosis of idiopathic Parkinson's disease (PD) within 6 months. It will also help researchers learn about the safety and bi…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Cancer-Killing virus takes on ovarian cancer in first human trial
Disease control Recruiting nowA research study evaluating a new oncolytic virus, THEO-260, in patients with advanced ovarian cancer. The trial will investigate different doses of THEO-260 administered by the intraperitoneal route to identify a dose that is safe, well tolerated, and exhibits preliminary eviden…
Phase: PHASE1 • Sponsor: Theolytics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New weekly shot could fight deadly mould infections with fewer side effects
Disease control Recruiting nowThe purpose of this study is to determine if EL219 is safe and effective compared to liposomal amphotericin B (LAmB) or voricanozole for early treatment of invasive mould infections
Phase: PHASE2 • Sponsor: Elion Therapeutics, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New shot could boost opioid recovery, early trial hopes
Disease control Recruiting nowThe purpose of this study is to see if brenipatide, when compared to placebo, is safe and effective for participants with opioid use disorder, when used with buprenorphine with or without naloxone. The maximum potential duration of study participation for a participant in Part A…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Beauty salons join fight against HIV: new online program aims to boost PrEP use among black women
Prevention Recruiting nowThe goal of this clinical trial is to test a new online program called UPDOs Protective Styles to help people in the southeastern United States learn about and start using PrEP (pre-exposure prophylaxis), a medicine that helps prevent HIV. The study focuses on people who may be a…
Phase: NA • Sponsor: Duke University • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
New smart drug targets tough cancers in first human trial
Disease control Recruiting nowThe purpose of this first-in-human (FIH) study is to evaluate the safety, tolerability, Pharmacokinetics (PK), and preliminary clinical activity of M7437 in participants with locally advanced or metastatic solid tumors with known Ly6E expression, including non-small cell lung can…
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug HU6 targets fatty liver disease in Mid-Stage trial
Disease control Recruiting nowRivus Pharmaceuticals. Inc. is sponsoring this research study to assess the safety and tolerability of HU6 as a possible treatment for patients diagnosed with metabolic dysfunction-associated steatohepatitis (MASH). The study will also assess safety, pharmacokinetics (PK) and cha…
Phase: PHASE2 • Sponsor: Rivus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a tiny dose of a diabetes drug stop weight regain in HIV patients?
Disease control Recruiting nowThe objectives of this study are as follows: Primary Objective * To determine the rate of weight regain in people living with human immunodeficiency virus (HIV) (PWH) receiving semaglutide microdosing vs. no additional drug following induction therapy. Secondary Objectives * …
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug combo targets Hard-to-Treat cancers with genetic weakness
Disease control Recruiting nowThe goal of this clinical research study is to learn about the safety and effects of BMS-986504 in combination with olaparib in patients with advanced solid tumors with MTAP loss.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC